{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:54:32Z","timestamp":1792421672748,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21wm0425015"],"award-info":[{"award-number":["JP21wm0425015"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24wm0625001"],"award-info":[{"award-number":["JP24wm0625001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-93520-5","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:45:56Z","timestamp":1741844756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Human biodistribution and radiation dosimetry of two novel \u03b1-synuclein PET tracers, 18F-SPAL-T-06 and 18F-C05-05"],"prefix":"10.1038","volume":"15","author":[{"given":"Ryoji","family":"Goto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiwamu","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Oya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosei","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Tagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Takahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"93520_CR1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s004010050918","volume":"96","author":"K Wakabayashi","year":"1998","unstructured":"Wakabayashi, K. et al. Accumulation of alpha-synuclein\/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol. 96, 445\u2013452 (1998).","journal-title":"Acta Neuropathol."},{"key":"93520_CR2","doi-asserted-by":"crossref","unstructured":"Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U. S. A. 95, 6469\u20136473 (1998).","DOI":"10.1073\/pnas.95.11.6469"},{"key":"93520_CR3","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba, M. et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am. J. Pathol. 152, 879\u2013884 (1998).","journal-title":"Am. J. Pathol."},{"key":"93520_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0006-8993(98)00734-3","volume":"808","author":"K Arima","year":"1998","unstructured":"Arima, K. et al. Immunoelectron-microscopic demonstration of NACP\/\u03b1-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson\u2019s disease and in dementia with lewy bodies. Brain Res. 808, 93\u2013100 (1998).","journal-title":"Brain Res."},{"key":"93520_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","volume":"249","author":"K Wakabayashi","year":"1998","unstructured":"Wakabayashi, K., Yoshimoto, M., Tsuji, S. & Takahashi, H. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci. Lett. 249, 180\u2013182 (1998).","journal-title":"Neurosci. Lett."},{"key":"93520_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0304-3940(02)01258-2","volume":"336","author":"M Takahashi","year":"2003","unstructured":"Takahashi, M. et al. Phosphorylation of alpha-synuclein characteristic of synucleinopathy lesions is recapitulated in alpha-synuclein transgenic Drosophila. Neurosci. Lett. 336, 155\u2013158 (2003).","journal-title":"Neurosci. Lett."},{"key":"93520_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.expneurol.2017.10.003","volume":"298","author":"P Brundin","year":"2017","unstructured":"Brundin, P., Dave, K. D. & Kordower, J. H. Therapeutic approaches to target alpha-synuclein pathology. Exp.Neurol. 298, 225\u2013235 (2017).","journal-title":"Exp. Neurol."},{"key":"93520_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.parkreldis.2020.01.010","volume":"73","author":"A Heras-Garvin","year":"2020","unstructured":"Heras-Garvin, A. & Stefanova, N. MSA: From basic mechanisms to experimental therapeutics. Parkinsonism Relat. Disord. 73, 94\u2013104 (2020).","journal-title":"Parkinsonism Relat. Disord"},{"key":"93520_CR9","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1002\/mds.29186","volume":"37","author":"K Matsuoka","year":"2022","unstructured":"Matsuoka, K. et al. High-contrast imaging of \u03b1-synuclein pathologies in living patients with multiple system atrophy. Mov. Disord. 37, 2159\u20132161 (2022).","journal-title":"Mov. Disord"},{"key":"93520_CR10","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1016\/j.neuron.2024.05.006","volume":"112","author":"H Endo","year":"2024","unstructured":"Endo, H. et al. Imaging \u03b1-synuclein pathologies in animal models and patients with Parkinson\u2019s and related diseases. Neuron 112, 2540\u20132557 (2024).","journal-title":"Neuron"},{"key":"93520_CR11","first-page":"1","volume":"37","author":"The 2007 Recommendations of the International Commission on Radiological Protection","year":"2007","unstructured":"The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann. ICRP. 37, 1\u2013332 (2007).","journal-title":"Ann. ICRP"},{"key":"93520_CR12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s12149-019-01366-5","volume":"33","author":"M Nakano","year":"2019","unstructured":"Nakano, M. et al. Radiation dosimetry and pharmacokinetics of florbetapir (18F) in Japanese subjects. Ann. Nucl. Med. 33, 639\u2013645 (2019).","journal-title":"Ann. Nucl. Med."},{"key":"93520_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s12149-015-0986-2","volume":"29","author":"M Senda","year":"2015","unstructured":"Senda, M. et al. The clinical safety, biodistribution and internal radiation dosimetry of flutemetamol (18F) injection in healthy Japanese adult volunteers. Ann. Nucl. Med. 29, 627\u2013635 (2015).","journal-title":"Ann. Nucl. Med."},{"key":"93520_CR14","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.2967\/jnumed.116.189126","volume":"58","author":"IT Hsiao","year":"2017","unstructured":"Hsiao, I. T. et al. Biodistribution and radiation dosimetry for the tau tracer 18F-THK-5351 in healthy human subjects. J. Nucl. Med. 58, 1498\u20131503 (2017).","journal-title":"J. Nucl. Med."},{"key":"93520_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11307-019-01367-w","volume":"22","author":"M Koole","year":"2020","unstructured":"Koole, M. et al. Preclinical safety evaluation and human dosimetry of [18F]MK-6240, a novel PET tracer for imaging neurofibrillary tangles. Mol. Imaging Biol. 22, 173\u2013180 (2020).","journal-title":"Mol. Imaging Biol."},{"key":"93520_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s12149-023-01828-x","volume":"37","author":"M Miyamoto","year":"2023","unstructured":"Miyamoto, M. et al. Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects. Ann. Nucl. Med. 37, 300\u2013309 (2023).","journal-title":"Ann. Nucl. Med."},{"key":"93520_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11307-015-0924-7","volume":"18","author":"JY Choi","year":"2016","unstructured":"Choi, J. Y. et al. Human radiation dosimetry of [(18)F]AV-1451(T807) to detect tau pathology. Mol. Imaging Biol. 18, 479\u2013482 (2016).","journal-title":"Mol. Imaging Biol."},{"key":"93520_CR18","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.2967\/jnumed.118.209916","volume":"59","author":"DF Wong","year":"2018","unstructured":"Wong, D. F. et al. Characterization of 3 novel tau radiopharmaceuticals, 11C-RO-963, 11C-RO-643, and 18F-RO-948, in healthy controls and in alzheimer subjects. J. Nucl. Med. 59, 1869\u20131876 (2018).","journal-title":"J. Nucl. Med."},{"key":"93520_CR19","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s00259-010-1447-8","volume":"37","author":"Y Kimura","year":"2010","unstructured":"Kimura, Y. et al. Biodistribution and radiation dosimetry of a positron emission tomographic ligand, 18F-SP203, to image metabotropic glutamate subtype 5 receptors in humans. Eur. J. Nucl. Med. Mol. Imaging. 37, 1943\u20131949 (2010).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"93520_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00004032-197308000-00009","volume":"25","author":"RJ Cloutier","year":"1973","unstructured":"Cloutier, R. J., Smith, S. A., Watson, E. E., Snyder, W. S. & Warner, G. G. Dose to the fetus from radionuclides in the bladder. Health Phys. 25, 147\u2013161 (1973).","journal-title":"Health Phys."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93520-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93520-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93520-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:27:42Z","timestamp":1741886862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93520-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93520"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93520-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ming-Rong Zhang and Makoto Higuchi are inventors of a patent application in relation to the imaging agents documented in this report, 18F-SPAL-T-06 (PCT\/JP2021\/30899) and 18F-C05-05 (2019-034997, PCT\/JP2020\/002607). All other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board of the National Institutes for Quantum Science and Technology and was performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. The studies were registered with the Japan Registry for Clinical Trials (jRCTs031210180 and jRCTs031220123).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All images are entirely unidentifiable and there are no details on the individuals reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Written informed consent was obtained from all participants or their caregivers.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate (including appropriate statements)"}}],"article-number":"8640"}}